Oct 07, 2021 / NTS GMT
Presentation
Oct 07, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Hiroki Sakai
* Kenji Morishima
Santen Pharmaceutical Co., Ltd. - Corporate Officer & Head of China Product Development Department
* Peter Sallstig
* Reza Haque
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, CEO & Representative Director
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shohei Oda
Morgan Stanley, Research Division - Research Associate
=====================
Santen Pharmaceutical Co Ltd
(OTCPK:SNPHF)
$
13.05
+0.55 (+4.4%)
Market Cap: 4.23 Bil
Enterprise Value: 3.71 Bil
PE Ratio: 18.70
PB Ratio: 2.31
GF Score: 81/100 Santen Pharmaceutical Co Ltd Product Invention Presentation Transcript
Oct 07, 2021 / NTS GMT
Release Date Price:
$13.37
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot